An investment of up to $550 million by 2030 will establish the Indianapolis site as a hub for manufacturing of Roche’s continuous glucose monitoring solution. Roche, announced it plans
USD 50 billion commitment includes new state-of-the art research and development (R&D) sites, new and expanded manufacturing facilities in Indiana, Pennsylvania, Massachusetts and California and
Roche announced that Wafaa Mamilli (1967) will join the company as Chief Digital Technology Officer (CDTO), reporting to Group CEO, Thomas Schinecker, and will become a member of
The potential for artificial intelligence AI in healthcare is exploding, with economists now predicting AI could narrow deficits in the USA by improving health care. The US Food and Drug
Fuel up with free Health Tech Insights
